Global Biological Implants Market Growth (Status and Outlook) 2023-2029

Global Biological Implants Market Growth (Status and Outlook) 2023-2029

A biological implant is manufactured to replace a damaged or missing biological structure. Biological implants are man made devices and design to help the biological anatomy function.

Biological implants help replace or stabilize injured tissue and are used in non-union repair, fractures, lens prosthesis, total joint replacements.

LPI (LP Information)' newest research report, the “Biological Implants Industry Forecast” looks at past sales and reviews total world Biological Implants sales in 2022, providing a comprehensive analysis by region and market sector of projected Biological Implants sales for 2023 through 2029. With Biological Implants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Implants industry.

This Insight Report provides a comprehensive analysis of the global Biological Implants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological Implants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biological Implants market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Implants and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Implants.

The global Biological Implants market size is projected to grow from US$ 5322.2 million in 2022 to US$ 7228.3 million in 2029; it is expected to grow at a CAGR of 4.5% from 2023 to 2029.

In 2017, North America accounted for the largest share of over 50%. This largest share is attributed to the simultaneous development of surgical procedures for extremities using implants. Also, presence of large number of key participants operating in this region coupled with high incidence of accidental injury that features most of the reconstructive procedures are expected to project demand for this market in North America.

This report presents a comprehensive overview, market shares, and growth opportunities of Biological Implants market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Autografts
Allografts
Xenografts

Segmentation by application
Cardiovascular Implants
Orthopedic Implants
Dental Implants
Soft Tissue Implants

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Integra LifeSciences Corporation
NuVasive, Inc
Edward LifeSciences Corporation
Stryker Corporation
LifeCell corporation
Medtronic
RTI Surgical, Inc
BioPolymer GmbH & Co. KG
Johnson & Johnson
Baxter International, Inc.
Vericel Corporation
Alphatec Spine, Inc
CryoLife
Maxigen Biotech, Inc.
IOP Ophthalmic Products, Inc.
CONMED
Allergan Plc
BioTissue
Auto Tissue Berlin GmbH
MiMedx Group, Inc.
Organogenesis, Inc.
Osiris Therapeutics, Inc.

Please note: The report will take approximately 2 business days to prepare and deliver.